Background and aims: Clinicopathological features of Basal-like Breast Cancer (BLBC) in African American women have been extensively studied. Comparatively, less is known about these tumors in patients from countries in the North African region. The aim of this study was to assess the frequency and clinicopathological characteristics of BLBC in Egyptian patients with comparison to British patients. Material and methods: Tissue microarray blocks were constructed from primary invasive breast cancer from 321 Egyptian and 527 British BC patients. Sections were stained immunohistochemically with oestrogen receptor (ER), progesterone receptor (PR), HER2, CK19, CK14, EGFR, CK5/6, P53 and Ki67. BLBC phenotype was identified by lacking of staining o...
Background: Breast cancer is the most common malignancy accounting for 25% of all cancers in females...
Abstract Introduction Breast cancer is a heterogeneous disease with varying clinical outcomes in his...
Abstract Risk factors for the newly identified “intrinsic ” breast cancer subtypes (luminal A, lumin...
Background and aims: Clinicopathological features of Basal-like Breast Cancer (BLBC) in African Amer...
Abstract Background Prognostic markers and molecular breast cancer subtypes reflect underlying biolo...
Understanding molecular characteristics that distinguish inflammatory breast cancer (IBC) from non-I...
Background: Grade-III invasive ductal carcinomas of no special type (IDCs-NST) constitute a heteroge...
Background: The aim of this study was to evaluate the prognostic significance of the basal cell-like...
Introduction: Breast carcinomas are heterogeneous disease with different prognosis and therapy respo...
Breast cancer is a heterogeneous disease comprising five major subtypes including luminal A, luminal...
Background Some studies have suggested that breast cancer in black women is more aggressive than in ...
Background: Breast cancer subtype can be classified using standard clinical markers (estrogen recept...
Breast cancer is recognised to be a heterogeneous disease and the second most common cause of morbid...
Interest in identifying populations with triple negative (TN) and basal-like breast cancer stems fro...
Purpose The objective of this study was to compare tumor characteristics, biomarkers, and surrogate ...
Background: Breast cancer is the most common malignancy accounting for 25% of all cancers in females...
Abstract Introduction Breast cancer is a heterogeneous disease with varying clinical outcomes in his...
Abstract Risk factors for the newly identified “intrinsic ” breast cancer subtypes (luminal A, lumin...
Background and aims: Clinicopathological features of Basal-like Breast Cancer (BLBC) in African Amer...
Abstract Background Prognostic markers and molecular breast cancer subtypes reflect underlying biolo...
Understanding molecular characteristics that distinguish inflammatory breast cancer (IBC) from non-I...
Background: Grade-III invasive ductal carcinomas of no special type (IDCs-NST) constitute a heteroge...
Background: The aim of this study was to evaluate the prognostic significance of the basal cell-like...
Introduction: Breast carcinomas are heterogeneous disease with different prognosis and therapy respo...
Breast cancer is a heterogeneous disease comprising five major subtypes including luminal A, luminal...
Background Some studies have suggested that breast cancer in black women is more aggressive than in ...
Background: Breast cancer subtype can be classified using standard clinical markers (estrogen recept...
Breast cancer is recognised to be a heterogeneous disease and the second most common cause of morbid...
Interest in identifying populations with triple negative (TN) and basal-like breast cancer stems fro...
Purpose The objective of this study was to compare tumor characteristics, biomarkers, and surrogate ...
Background: Breast cancer is the most common malignancy accounting for 25% of all cancers in females...
Abstract Introduction Breast cancer is a heterogeneous disease with varying clinical outcomes in his...
Abstract Risk factors for the newly identified “intrinsic ” breast cancer subtypes (luminal A, lumin...